充血性心力衰竭 - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Cardiac Contractility Modulation
Lifestyle Modifications for Preventing and Treating Heart Failure
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5)
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
H2FPEF Score for Predicting Future Heart Failure in Stable Outpatients With Cardiovascular Risk Factors
Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure

Recommandation Statement

2018 May 15;137(20):e578-e622.

JOURNAL：Circulation.

Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

Konstam MA, Kiernan MS, American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia.

4265

Keywords: AHA Scientific Statements; causality; disease management; heart failure; ventricular dysfunction, right

FULL TEXT PDF